FDA recall, , Moderate risk
American Red Cross Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were labeled as antigen negative but came from a donor who tested positive.
Recall ended Sep 22, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The National American Red Cross began a recall of Red Blood Cells, Leukocytes Reduced on December 18, 2025. The agency stated that the product was labeled as antigen negative but was collected from a donor who subsequently tested antigen positive. The recall was added to the FDA's Enforcement Report on September 22, 2026, and was listed in the FDA's weekly enforcement report on September 30, 2026, for Illinois.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- The National American Red Cross
- Hazard
- Labeling error
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99721
- Recall number
- B-0224-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
